This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Boris Pinchuk
Introduction
Boris Pinchuk is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical diagnostics and therapeutic applications.
Latest Patents
Boris Pinchuk holds a patent for "Anti-thymidine kinase antibodies." This invention relates to a novel monoclonal antibody that specifically binds to a conformation-dependent epitope on human thymidine kinase 1 (hTK-1; SEQ ID NO:1). The patent also includes methods for quantifying hTK-1 using the antibody and the use of the anti-hTK-1 antibody in quantifying hTK-1. He has 1 patent to his name.
Career Highlights
Throughout his career, Boris has worked with prominent companies in the biotechnology sector. He has been associated with Roche Diagnostics Operations, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in medical technology.
Collaborations
Boris has collaborated with several professionals in his field, including Frank Kroner and Michael Schraeml. These collaborations have enriched his work and expanded the impact of his inventions.
Conclusion
Boris Pinchuk's contributions to the field of biotechnology, particularly through his patent on anti-thymidine kinase antibodies, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of diagnostic tools and therapies.